Free Pick from Jeff Brown: “Buy S.C.G .”
Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”
Click here and get the name and ticker symbol!
John D. Young, insider at Pfizer
John D. Young Insider Alerts

Get notified the next time John D. Young buys or sells Pfizer stock. Enter your email address below to get our daily insider buying and selling report.

John D. Young Insider Information

Insider of Pfizer
John Young is Group President at Pfizer Inc., and is a member of the Company’s Executive Leadership Team.

Prior to this role, John was the Group President of Pfizer Innovative Health, which included six business units: Internal Medicine, Inflammation & Immunology, Oncology, Rare Disease, Vaccines and Consumer Healthcare; each business unit focused on developing innovative medicines and vaccines to make a meaningful difference to patients impacted by diseases with significant unmet need. John was also responsible for these businesses in Emerging Markets focused on increasing access to Pfizer’s innovative medicines to people across developing countries in Latin America, Asia, Africa and the Middle East.

Previously, John was the Group President for Pfizer Essential Health where he oversaw a broad portfolio of more than 600 products with a global reach in 160 countries. A scientist by training, John has more than 30 years of experience with Pfizer and has held a number of senior positions across the organization.

John is a member of the Board of Directors of the Consumer Healthcare Joint Venture with GlaxoSmithKline plc, and also Johnson Controls International (JCI). He serves on the Board of BIO (Biotechnology Innovation Organization) and as a member of the UK Government bioscience working group, the Life Sciences Council.

John holds a BSc in Biological Science from Glasgow University and an MBA from Strathclyde Graduate Business School. He is married with three daughters.

What is John D. Young's net worth?

The estimated net worth of John D. Young is at least $10.83 million as of May 10th, 2016. Mr. Young owns 200,399 shares of Pfizer stock worth more than $10,831,566 as of January 20th. This net worth evaluation does not reflect any other assets that Mr. Young may own. Learn More.

What is John D. Young's salary?

As the Insider of Pfizer Inc., Mr. Young earned a total compensation package of $8,989,193.00 in 2020. Mr. Young earned a salary of $1,285,000.00, stock awards of $1,814,734.00, options awards of $2,087,062.00, non-equity compensation of $1,800,000.00, and other compensation of $450,994.00.

How do I contact John D. Young?

The corporate mailing address for Mr. Young and other Pfizer executives is 235 EAST 42ND STREET, NEW YORK NY, 10017. Pfizer can also be reached via phone at (212) 733-2323.

Has John D. Young been buying or selling shares of Pfizer?

John D. Young has not been actively trading shares of Pfizer within the last three months. Most recently, John D. Young sold 150,000 shares of the business's stock in a transaction on Thursday, November 11th. The shares were sold at an average price of $50.06, for a transaction totalling $7,509,000.00.

Who are Pfizer's active insiders?

Pfizer's insider roster includes Jennifer Damico (SVP), Jennifer Damico (SVP), Douglas Lankler (EVP), Alexander Mackenzie (EVP), and John Young (Insider).

Are insiders buying or selling shares of Pfizer?

In the last year, insiders at the biopharmaceutical company sold shares 6 times. They sold a total of 238,021 shares worth more than $12,217,419.90. The most recent insider tranaction occured on December, 2nd when EVP Alexander R Mackenzie sold 41,360 shares worth more than $2,244,193.60. Insiders at Pfizer own 0.1 % of the company.

Information on this page was last updated on 12/2/2021.

John D. Young Insider Trading History at Pfizer

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/11/2021Sell150,000$50.06$7,509,000.00View SEC Filing Icon  
5/10/2016Sell41,700$33.53$1,398,201.00200,399View SEC Filing Icon  
11/7/2014Sell21,600$29.89$645,624.00View SEC Filing Icon  
See Full Table

John D. Young Buying and Selling Activity at Pfizer

This chart shows John D Young's buying and selling at Pfizer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pfizer Company Overview

Pfizer logo
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Read More

Today's Range

Now: $54.05
Low: $53.07
High: $54.52

50 Day Range

MA: $54.75
Low: $49.60
High: $61.25

2 Week Range

Now: $54.05
Low: $33.36
High: $61.71

Volume

34,833,765 shs

Average Volume

37,716,852 shs

Market Capitalization

$303.38 billion

P/E Ratio

16.09

Dividend Yield

2.91%

Beta

0.69
Free Pick from Jeff Brown: “Buy S.C.G .”
Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”
Click here and get the name and ticker symbol!